Following the publication of the above article, a concerned reader drew to the Editor's attention that the Transwell cell migration and invasion assay data featured in Fig. 2C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports, or were under consideration for publication at around the same time (some of which have been retracted). Furthermore, a number of overlapping data panels were identified comparing the migration and invasion assay data in Figs. 5C and 6C, such that data which were intended to show the results from differently performed experiments appeared to have been derived from the same original source(s). In view of the fact that certain of these data had already apparently been published previously, and given the lack of rigour on the part of the authors in assembling the data in Figs. 5 and 6, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 37: 501‑509, 2017; DOI: 10.3892/or.2016.5242].

中文翻译：

---

[撤回] MicroRNA-362 在宫颈癌中下调，并通过直接靶向 SIX1 抑制细胞增殖、迁移和侵袭。

上述文章发表后，一位关心的读者提请编辑注意，图2C中的Transwell细胞迁移和侵袭实验数据与不同研究机构不同作者撰写的其他文章中以不同形式出现的数据惊人相似在将本文提交给《肿瘤学报告》之前，这些文章要么已经在其他地方发表，要么正在考虑在大约同一时间发表（其中一些已被撤回）。此外，通过比较图1和2中的迁移和入侵测定数据，确定了许多重叠的数据组。如图5C和6C所示，使得旨在显示来自不同执行的实验的结果的数据似乎源自相同的原始来源。鉴于这些数据中的某些显然之前已经发表，并且考虑到作者在组装图1和2中的数据时缺乏严谨性，因此， 5 日和 6 日， Oncology Reports编辑决定从期刊中撤回这篇论文。作者被要求对这些担忧做出解释，但编辑部没有收到满意的答复。编辑对给读者带来的任何不便表示歉意。 [肿瘤学报告 37：501-509，2017 年； DOI：10.3892/或.2016.5242]。